Endosense
ExitedMedical company focused on improving the efficacy;safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias
Endosense has raised €59M across 3 funding rounds from 3 investors, most recently a Series C round in Mar 2013. Based in Geneva, Switzerland; founded 2003; active in Healthtech. Acquired by St. Jude Medical in 2010. Data as of 28 Oct 2026.
Total raised
€59M
€58,877,019
Funding rounds
3
Investors
3
distinct backers
Active since
2009-10
latest 2013-03
Funding by year
EUR raised per yearEndosense — funding by year — interactive chart.
Data table
| Endosense — funding by year | |
|---|---|
| 2009 | €25M |
| 2012 | €31M |
| 2013 | €3.3M |
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-03-01 | Series C | €3.3M | — | View deal → |
| 2012-11-01 | Series C | €31M | GIMV,Ysios Capital | View deal → |
| 2009-10-01 | Series B | €25M | GIMV,NeoMed,Ysios Capital | View deal → |
Exit
Type
acquisition
Date
May 2010
Value
€155M
Acquiror
St. Jude Medical (United States Saint Paul)
Investors
3Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData